Oruka Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Menlo Park, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oruka Therapeutics, Inc. has filed 1,526 SEC EDGAR filings since 12 Jun 1997

SEC filing history

Showing 51-75 of 244 matching filings.

Per page
25
Current page
3
8-K File 000-22873

8-K

Filing date
10 Jun 2021
Reporting date
10 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
11 May 2021
Reporting date
11 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
03 May 2021
Reporting date
03 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
06 Apr 2021
Reporting date
02 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
18 Mar 2021
Reporting date
18 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
02 Feb 2021
Reporting date
29 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
23 Dec 2020
Reporting date
21 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
15 Dec 2020
Reporting date
15 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
10 Dec 2020
Reporting date
10 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
23 Nov 2020
Reporting date
23 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
02 Nov 2020
Reporting date
02 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
07 Oct 2020
Reporting date
07 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
21 Sep 2020
Reporting date
21 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .